Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. In
recent years, many disease-modifying therapies (DMT) have been approved for MS …

Multiple sclerosis (MS) is an inflammatory, demyelinating, neurodegenerative, immune-
mediated disease primarily diagnosed in early adulthood. Multiple sclerosis mostly impacts …

Multiple sclerosis (MS) is a chronic disease affecting the brain and the spinal cord. It is a
chronic inflammatory demyelinating disease of the central nervous system. It is the leading …

Autoimmune neurological disorders are commonly treated with immunosuppressive therapy.
In patients with refractory conditions, standard immunosuppression is often insufficient for …

Multiple sclerosis (MS) is an inflammatory disease mainly affecting the central nervous
system. In MS, abnormal immune mechanisms induce acute inflammation, demyelination …

Introduction Plasmapheresis is a well‐recognized treatment for autoimmune neurological
diseases in Japan. However, the practice varies depending on the facility, and the actual …

An evidence-based treatment for a Multiple Sclerosis (MS) relapse is an intravenous
administration of 3–5 g of Methylprednisolone. In case of insufficient effect or corticosteroids …

Abstract Purpose of Review Neuromyelitis optica spectrum disorder (NMOSD) is a rare but
highly disabling disease of the central nervous system. Unlike multiple sclerosis, disability in …

Background Multiple sclerosis (MS) is a rare but serious condition associated with significant
morbidity. Objective This review provides a focused assessment of MS for emergency …

Background There are no systematic reviews yet that evaluated the effects of PE/IA in
patients with optic neuritis (ON) in demyelinating diseases. A meta-analysis of available …